Squarepoint’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,728
Closed -$175K 2496
2023
Q3
$175K Buy
4,728
+1,825
+63% +$67.5K ﹤0.01% 2154
2023
Q2
$117K Sell
2,903
-1,368
-32% -$55.1K ﹤0.01% 2182
2023
Q1
$310K Buy
4,271
+2,641
+162% +$191K ﹤0.01% 1660
2022
Q4
$134K Sell
1,630
-6,526
-80% -$535K ﹤0.01% 1997
2022
Q3
$771K Buy
+8,156
New +$771K ﹤0.01% 1198
2021
Q2
Sell
-4,754
Closed -$1.71M 2608
2021
Q1
$1.71M Buy
4,754
+2,095
+79% +$752K 0.01% 796
2020
Q4
$1.31M Buy
2,659
+442
+20% +$217K 0.01% 938
2020
Q3
$718K Sell
2,217
-3,384
-60% -$1.1M 0.01% 1123
2020
Q2
$2.04M Buy
5,601
+4,034
+257% +$1.47M 0.03% 617
2020
Q1
$333K Buy
1,567
+856
+120% +$182K 0.01% 1246
2019
Q4
$293K Sell
711
-286
-29% -$118K ﹤0.01% 1982
2019
Q3
$352K Buy
+997
New +$352K ﹤0.01% 1732
2019
Q2
Sell
-1,159
Closed -$1.15M 2286
2019
Q1
$1.15M Buy
1,159
+501
+76% +$498K 0.01% 1025
2018
Q4
$571K Sell
658
-294
-31% -$255K 0.01% 1166
2018
Q3
$984K Sell
952
-464
-33% -$480K 0.01% 993
2018
Q2
$1.3M Buy
1,416
+968
+216% +$889K 0.02% 791
2018
Q1
$437K Sell
448
-370
-45% -$361K 0.01% 1134
2017
Q4
$370K Buy
+818
New +$370K 0.01% 1365
2017
Q1
Sell
-407
Closed -$145K 1510
2016
Q4
$145K Buy
+407
New +$145K 0.01% 1548
2016
Q2
Sell
-648
Closed -$308K 1094
2016
Q1
$308K Buy
648
+336
+108% +$160K 0.02% 813
2015
Q4
$206K Buy
+312
New +$206K 0.02% 981